Literature DB >> 3875857

Inhibition of soluble immune response suppressor activity by growth factors.

T M Aune.   

Abstract

Soluble immune response suppressor (SIRS), a protein of Mr 14,000, is a lymphokine produced by interferon- or concanavalin A-activated suppressor T cells and is oxidized to its activated form, SIRSox, by H2O2 produced by macrophages. SIRSox inhibits antibody secretion by B lymphocytes and cell division by normal or transformed cell lines. Effects of purified growth factors on suppression of antibody secretion were examined to determine whether any would oppose the inhibitory effects of SIRS or SIRSox. Interleukin 1 (IL-1), interleukin 2 (IL-2), and epidermal growth factor (EGF) each inhibited SIRS-mediated suppression of antibody secretion by cultured mouse spleen cells. Inhibition of SIRS activity was most effective when growth factors were added late in the culture period. IL-1, IL-2, and EGF also blocked suppression by SIRSox. However, EGF and IL-1 blocked suppression by SIRSox only when added 3-6 hr before addition of SIRSox, whereas IL-2 blocked suppression by SIRSox when added before or up to 3 hr after addition of SIRSox. Further evaluation showed that IL-2, but not EGF or IL-1, reversed inhibition of antibody secretion by SIRSox in a time- and concentration-dependent manner. With 50 units of IL-2 per 0.5-ml culture, reversal was complete within 1 hr. The ability of growth factors to interfere with inhibition of cell division by SIRSox was examined with the human B-cell leukemia RPMI-1788. This cell line binds EGF but is not known to have cell surface receptors for IL-1 or IL-2. EGF (0.3-1 ng/ml), when added to RPMI-1788 cultures 4-6 hr before SIRSox, interfered with the ability of SIRSox to inhibit cell division. Taken together, these data indicate that growth factors interfere with both the immunosuppressive and growth inhibitory properties of SIRSox in both heterogeneous and homogeneous cell populations.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3875857      PMCID: PMC391032          DOI: 10.1073/pnas.82.18.6260

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Automatic Monitoring of primary amines in preparative column effluents with fluorescamine.

Authors:  P Böhlen; S Stein; J Stone; S Udenfriend
Journal:  Anal Biochem       Date:  1975-08       Impact factor: 3.365

Review 2.  Epidermal growth factor.

Authors:  G Carpenter; S Cohen
Journal:  Annu Rev Biochem       Date:  1979       Impact factor: 23.643

3.  Purification and initial characterization of the lymphokine soluble immune response suppressor.

Authors:  T M Aune; D R Webb; C W Pierce
Journal:  J Immunol       Date:  1983-12       Impact factor: 5.422

4.  Interleukin 1, a potential regulator of fibroblast proliferation.

Authors:  J A Schmidt; S B Mizel; D Cohen; I Green
Journal:  J Immunol       Date:  1982-05       Impact factor: 5.422

5.  Isolation of native microtubules from porcine brain and characterization of SH groups essential for polymerization at the GTP binding sites.

Authors:  K Mann; M Giesel; H Fasold; W Haase
Journal:  FEBS Lett       Date:  1978-08-01       Impact factor: 4.124

6.  Receptor remodeling and regulation in the action of epidermal growth factor.

Authors:  C F Fox; P S Linsley; M Wrann
Journal:  Fed Proc       Date:  1982-11

7.  Induction of suppressor T cells by interleukin 2.

Authors:  C C Ting; S S Yang; M E Hargrove
Journal:  J Immunol       Date:  1984-07       Impact factor: 5.422

8.  Modification of cellular protein sulfhydryl groups by activated soluble immune response suppressor.

Authors:  T M Aune
Journal:  J Immunol       Date:  1984-08       Impact factor: 5.422

9.  Preparation of soluble immune response suppressor and macrophage-derived suppressor factor.

Authors:  T M Aune; C W Pierce
Journal:  J Immunol Methods       Date:  1982-08-27       Impact factor: 2.303

10.  Immune responses in vitro. 3. Development of primary gamma-M, gamma-G, and gamma-A plaque-forming cell responses in mouse spleen cell cultures stimulated with heterologous erythrocytes.

Authors:  C W Pierce; B M Johnson; H E Gershon; R Asofsky
Journal:  J Exp Med       Date:  1971-08-01       Impact factor: 14.307

View more
  2 in total

1.  Epidermal growth factor prolongs survival time of tumor-bearing mice.

Authors:  H Amagase; K Tamura; M Okuhira; M Kakimoto; H Amano; K Hashimoto; T Fuwa; S Tsukagoshi
Journal:  Jpn J Cancer Res       Date:  1990-05

2.  Developing cerium modified gold nanoclusters for the treatment of advanced-stage rheumatoid arthritis.

Authors:  Sen Lin; Wei Gao; Jiachen Sun; Kai Gao; Dan Li; Xifan Mei
Journal:  Mater Today Bio       Date:  2022-06-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.